Mosaic ImmunoEngineering Inc. (CPMV) › Operating Cash FlowMosaic ImmunoEngineering Inc. (CPMV) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$4.32M2012: -$2.40M2013: -$1.01M2014: -$1.50M2015: -$1.34M2016: -$1.58M2017: -$1.31M2018: -$880.2K2019: -$760.8K2020: -$986.8K2021: -$679.2K2022: -$690.1K2023: -$497.5K2024: -$241.2K2025: -$111.4K-$111.4K2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$111.4K+53.8%2024-$241.2K+51.5%2023-$497.5K+27.9%2022-$690.1K-1.6%2021-$679.2K+31.2%2020-$986.8K-29.7%2019-$760.8K+13.6%2018-$880.2K+32.9%2017-$1.31M+16.9%2016-$1.58M-17.4%2015-$1.34M+10.6%2014-$1.50M-48.9%2013-$1.01M+57.9%2012-$2.40M+44.4%2011-$4.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share